These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 12911044)

  • 1. Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life.
    Mueller PS; Hook CC; Hayes DL
    Mayo Clin Proc; 2003 Aug; 78(8):959-63. PubMed ID: 12911044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness. An ethical distinction.
    Kay GN; Bittner GT
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):336-9; discussion 339. PubMed ID: 19808484
    [No Abstract]   [Full Text] [Related]  

  • 3. Ethical analysis of withdrawing ventricular assist device support.
    Mueller PS; Swetz KM; Freeman MR; Carter KA; Crowley ME; Severson CJ; Park SJ; Sulmasy DP
    Mayo Clin Proc; 2010 Sep; 85(9):791-7. PubMed ID: 20584919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients.
    Kapa S; Mueller PS; Hayes DL; Asirvatham SJ
    Mayo Clin Proc; 2010 Nov; 85(11):981-90. PubMed ID: 20843982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy.
    Kramer DB; Kesselheim AS; Salberg L; Brock DW; Maisel WH
    Am J Cardiol; 2011 Apr; 107(7):1071-1075.e5. PubMed ID: 21296323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating permanent pacemaker in patients with terminalillness. Patient autonomy is paramount.
    Zellner RA; Aulisio MP; Lewis WR
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):340-4; discussion 340. PubMed ID: 19808485
    [No Abstract]   [Full Text] [Related]  

  • 7. Considerations in Patients With Cardiac Implantable Electronic Devices at End of Life.
    Gura MT
    AACN Adv Crit Care; 2015; 26(4):356-63. PubMed ID: 26484996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac pacemakers and implantable defibrillators in terminal care.
    Braun TC; Hagen NA; Hatfield RE; Wyse DG
    J Pain Symptom Manage; 1999 Aug; 18(2):126-31. PubMed ID: 10484860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawing implantable defibrillator shock therapy in terminally ill patients.
    Lewis WR; Luebke DL; Johnson NJ; Harrington MD; Costantini O; Aulisio MP
    Am J Med; 2006 Oct; 119(10):892-6. PubMed ID: 17000222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pacemaker deactivation: withdrawal of support or active ending of life?
    Huddle TS; Amos Bailey F
    Theor Med Bioeth; 2012 Dec; 33(6):421-33. PubMed ID: 22351107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal of nonfutile life support after attempted suicide.
    Brown SM; Elliott CG; Paine R
    Am J Bioeth; 2013; 13(3):3-12. PubMed ID: 23428025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is pacemaker deactivation at the end of life unique? A case study and ethical analysis.
    Whitlock SN; Goldberg IP; Singh JP
    J Palliat Med; 2011 Oct; 14(10):1184-8. PubMed ID: 21882901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ethics of pacemaker deactivation in terminally ill patients.
    Bevins MB
    J Pain Symptom Manage; 2011 Jun; 41(6):1106-10. PubMed ID: 21621131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicolegal issues arising when pacemaker and implantable cardioverter defibrillator devices are deactivated in terminally ill patients.
    McGeary A; Eldergill A
    Med Sci Law; 2010 Jan; 50(1):40-4. PubMed ID: 20349694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes.
    Mueller PS; Jenkins SM; Bramstedt KA; Hayes DL
    Pacing Clin Electrophysiol; 2008 May; 31(5):560-8. PubMed ID: 18439169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deactivating cardiac pacemakers and implantable cardioverter defibrillators in terminally ill patients.
    Beca JP; Rosselot E; Asenjo R; Anguita V; Quevedo R
    Camb Q Healthc Ethics; 2009; 18(3):236-40. PubMed ID: 19460224
    [No Abstract]   [Full Text] [Related]  

  • 17. [Deactivating pacemakers in terminally ill patients].
    Hotvedt R
    Tidsskr Nor Laegeforen; 2008 Aug; 128(15):1680. PubMed ID: 18704136
    [No Abstract]   [Full Text] [Related]  

  • 18. Withdrawal of cardiac medications and devices.
    Wiegand DL; Kalowes PG
    AACN Adv Crit Care; 2007; 18(4):415-25. PubMed ID: 17978616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Features and outcomes of patients who underwent cardiac device deactivation.
    Buchhalter LC; Ottenberg AL; Webster TL; Swetz KM; Hayes DL; Mueller PS
    JAMA Intern Med; 2014 Jan; 174(1):80-5. PubMed ID: 24276835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defibrillator patients should not be denied a peaceful death.
    Westerdahl AK; Sutton R; Frykman V
    Int J Cardiol; 2015 Mar; 182():440-6. PubMed ID: 25597981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.